Copyright Reports & Markets. All rights reserved.

Global Acquired Infections Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Acquired Infections Testing Market Overview

    • 1.1 Product Overview and Scope of Acquired Infections Testing
    • 1.2 Classification of Acquired Infections Testing by Types
      • 1.2.1 Global Acquired Infections Testing Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Acquired Infections Testing Revenue Market Share by Types in 2018
      • 1.2.3 Disease Testing
      • 1.2.4 Drug-Resistance Testing
    • 1.3 Global Acquired Infections Testing Market by Application
      • 1.3.1 Global Acquired Infections Testing Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Hospital
      • 1.3.3 Clinics
      • 1.3.4 Ambulatory Surgery Centers (ASC)
      • 1.3.5 Others
    • 1.4 Global Acquired Infections Testing Market by Regions
      • 1.4.1 Global Acquired Infections Testing Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Acquired Infections Testing Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Acquired Infections Testing Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acquired Infections Testing Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Acquired Infections Testing Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acquired Infections Testing Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Acquired Infections Testing (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Gen-Probe
      • 2.1.1 Business Overview
      • 2.1.2 Acquired Infections Testing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Gen-Probe Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Siemens AG
      • 2.2.1 Business Overview
      • 2.2.2 Acquired Infections Testing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Siemens AG Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Alere
      • 2.3.1 Business Overview
      • 2.3.2 Acquired Infections Testing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Alere Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Cephei
      • 2.4.1 Business Overview
      • 2.4.2 Acquired Infections Testing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Cephei Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Roche
      • 2.5.1 Business Overview
      • 2.5.2 Acquired Infections Testing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Roche Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Abbott Laboratories
      • 2.6.1 Business Overview
      • 2.6.2 Acquired Infections Testing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Abbott Laboratories Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Qiagen GmbH
      • 2.7.1 Business Overview
      • 2.7.2 Acquired Infections Testing Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Qiagen GmbH Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Becton Dickinson
      • 2.8.1 Business Overview
      • 2.8.2 Acquired Infections Testing Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Becton Dickinson Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Meridian Bioscience, Inc.
      • 2.9.1 Business Overview
      • 2.9.2 Acquired Infections Testing Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Meridian Bioscience, Inc. Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 bioMerieux
      • 2.10.1 Business Overview
      • 2.10.2 Acquired Infections Testing Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 bioMerieux Acquired Infections Testing Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Acquired Infections Testing Market Competition, by Players

    • 3.1 Global Acquired Infections Testing Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Acquired Infections Testing Players Market Share
      • 3.2.2 Top 10 Acquired Infections Testing Players Market Share
    • 3.3 Market Competition Trend

    4 Global Acquired Infections Testing Market Size by Regions

    • 4.1 Global Acquired Infections Testing Revenue and Market Share by Regions
    • 4.2 North America Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 4.5 South America Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Acquired Infections Testing Revenue and Growth Rate (2014-2019)

    5 North America Acquired Infections Testing Revenue by Countries

    • 5.1 North America Acquired Infections Testing Revenue by Countries (2014-2019)
    • 5.2 USA Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Acquired Infections Testing Revenue and Growth Rate (2014-2019)

    6 Europe Acquired Infections Testing Revenue by Countries

    • 6.1 Europe Acquired Infections Testing Revenue by Countries (2014-2019)
    • 6.2 Germany Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 6.3 UK Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 6.4 France Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Acquired Infections Testing Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Acquired Infections Testing Revenue by Countries

    • 7.1 Asia-Pacific Acquired Infections Testing Revenue by Countries (2014-2019)
    • 7.2 China Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 7.5 India Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Acquired Infections Testing Revenue and Growth Rate (2014-2019)

    8 South America Acquired Infections Testing Revenue by Countries

    • 8.1 South America Acquired Infections Testing Revenue by Countries (2014-2019)
    • 8.2 Brazil Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Acquired Infections Testing Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Acquired Infections Testing by Countries

    • 9.1 Middle East and Africa Acquired Infections Testing Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Acquired Infections Testing Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Acquired Infections Testing Revenue and Growth Rate (2014-2019)

    10 Global Acquired Infections Testing Market Segment by Type

    • 10.1 Global Acquired Infections Testing Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Acquired Infections Testing Market Forecast by Type (2019-2024)
    • 10.3 Disease Testing Revenue Growth Rate (2014-2024)
    • 10.4 Drug-Resistance Testing Revenue Growth Rate (2014-2024)

    11 Global Acquired Infections Testing Market Segment by Application

    • 11.1 Global Acquired Infections Testing Revenue Market Share by Application (2014-2019)
    • 11.2 Acquired Infections Testing Market Forecast by Application (2019-2024)
    • 11.3 Hospital Revenue Growth (2014-2019)
    • 11.4 Clinics Revenue Growth (2014-2019)
    • 11.5 Ambulatory Surgery Centers (ASC) Revenue Growth (2014-2019)
    • 11.6 Others Revenue Growth (2014-2019)

    12 Global Acquired Infections Testing Market Size Forecast (2019-2024)

    • 12.1 Global Acquired Infections Testing Market Size Forecast (2019-2024)
    • 12.2 Global Acquired Infections Testing Market Forecast by Regions (2019-2024)
    • 12.3 North America Acquired Infections Testing Revenue Market Forecast (2019-2024)
    • 12.4 Europe Acquired Infections Testing Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Acquired Infections Testing Revenue Market Forecast (2019-2024)
    • 12.6 South America Acquired Infections Testing Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Acquired Infections Testing Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Hospital-acquired infections are the infections caused by bacterial, viral, and fungal pathogens. These infections can be acquired in clinical settings, such as nursing home, rehabilitation facility, outpatient clinic, or other clinical settings.

      Scope of the Report:
      The global Acquired Infections Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Acquired Infections Testing.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the Acquired Infections Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Acquired Infections Testing market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Gen-Probe
      Siemens AG
      Alere
      Cephei
      Roche
      Abbott Laboratories
      Qiagen GmbH
      Becton Dickinson
      Meridian Bioscience, Inc.
      bioMerieux

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Disease Testing
      Drug-Resistance Testing

      Market Segment by Applications, can be divided into
      Hospital
      Clinics
      Ambulatory Surgery Centers (ASC)
      Others

      Buy now